Clinical Trial

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

Recruiting
View on ClinicalTrials.gov →
Summary
The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in patients with cardiogenic shock due to isolated or predominant left ventricular failure.
Protocol Amendment History 3 changes
notable Trial sites expanded: 5 -> 8 locations 2026-07-17
notable Primary completion pushed: 2026-05-30 -> 2028-01-30 2026-07-17
minor Completion pushed: 2026-10-30 -> 2028-02-28 2026-07-17
Trial Details
NCT Number NCT07293923
Lead Sponsor Magenta Medical Ltd.
Conditions Cardiogenic Shock, Heart Failure, Acute Myocardial Infarction (AMI)
Enrollment 10 participants
Start Date 2025-11-05
Primary Completion 2028-01-30 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-16